Generation of Antimelanoma Cytotoxic T Lymphocytes from Healthy Donors after Presentation of Melanoma-associated Antigen-derived Epitopes by Dendritic Cells in Vitro

Cancer Research

Volumn 55, Issue 22, 1995, Pages 5330-5334

  Bakker, Alexander B H ^a   Marland, Gill ^a   de Boer, Annemiek J ^a   Huijbens, Richard J F ^a   Adema, Gosse J ^a   Figdor, Carl G ^a   Danen, Erik H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; INTERLEUKIN 4; MELANOMA ANTIGEN;

ACTIVE IMMUNIZATION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL DIFFERENTIATION; DENDRITIC CELLS; EPITOPES; HLA-A ANTIGENS; HUMAN; MELANOCYTES; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0028885112     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Knuth, A., Wolfel, T., and Meyer zum Buschenfelde, K. H. T cell responses to human malignant tumours. Cancer Surv., 13: 39–52, 1992.
2. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., de Plaen, E., van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643–1647, 1991.
3. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., de Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178:489–495,1993.
4. Gaugler, B., Vandeneynde, B., Vanderbruggen, P., Romero, P., Gaforio, J. J., Dep-laen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene Mage-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921–930, 1994.
5. Bakker, A. B. H., Schreurs, M. W. J., De Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gplOO is recognized by melanoma-derived rumor-infiltrating lymphocytes. J. Exp. Med., 179: 1005–1009, 1994.
6. Coulie, P. G., Brichard, V., Vanpel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., Deplaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35–42, 1994.
7. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515–3519, 1994.
8. Wang, X.-F., Robbins, P. F., Kawakami, Y., Kang, X.-Q., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799–804, 1995.
9. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L. J. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington), 264: 716–719, 1994.
10. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458–6462, 1994.
11. Bakker, A. B. H., Schreurs, M. W. J., Tafazzul, G., De Boer, A. J., Kawakami, Y., Adema, G. J., and Figdor, C. G. Identification of a novel peptide derived from the melanocyte-specific gplOO antigen as the dominant epitope recognized by an HLA-A2.1 restricted anti-melanoma CTL line. Int. J. Cancer, 62: 97–102, 1995.
12. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X.-Q., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with in vivo tumor regression. J. Immunol., 154: 3961–3968, 1995.
13. Wolfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K. H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759–764, 1994.
14. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347–352, 1994.
15. Grabbe, S., Beissert, S., Schwartz, T., and Granstein, R. D. Dendritic cells as initiators of tumor immune responses: a possible strategy for immunotherapy? Immunol. Today, 16: 117–121, 1995.
16. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83–93, 1994.
17. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 179: 1109–1118, 1994.
18. Kawakami, Y., Zakut, R., Topalian, S. L., Stotter, H., and Rosenberg, S. A. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol., 148: 638–643, 1992.
19. Salter, R. D., Howell, D. N., and Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics, 21: 235–246, 1985.
20. Espevik, T., and Nissen Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95: 99–105, 1986.
21. Eisinger, M., and Marko, O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. USA, 79: 2018–2022, 1982.
22. Smit, N. P., Westerhof, W., Asghar, S. S., Pavel, S., and Siddiqui, A. H. Large-scale cultivation of human melanocytes using collagen-coated Sephadex beads (cytodex 3). J. Invest. Dermatol., 92: 18–21, 1989.
23. Parham, P., and Brodsky, F. M. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol., 3: 277–299, 1981.
24. Parham, P., and Bodmer, W. F. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature (Lond.), 276: 397–399, 1978.
25. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91: 2105–2109, 1994.
26. Leerling, M. F., Vaessen, L. M., Reubsaet, C. H., Weimar, W., Ettekoven, H., Marsman, F. R., and Kreeftenberg, J. G. Quality control of anti human CD3 and CD4 monoclonal antibodies. Dev. Biol. Stand., 71: 191–200, 1990.
27. Seed, B., and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA, 84: 3365–3369, 1987.
28. Traversari, C., van der Bruggen, P., van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35: 145–152, 1992.
29. Adema, G. J., De Boer, A. J., van ’t Hullenaar, R., Denijn, M., Ruiter, D. J., Vogel, A. M., and Figdor, C. G. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am. J. Pathol., 143: 1579–1585, 1993.
30. Anichini, A., Maccalli, C., Mortarini, R., Salvi, S., Mazzocchi, A., Squarcina, P., Herlyn, M., and Parmiani, G. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J. Exp. Med., 177: 989–998, 1993.
31. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038–3043, 1994.
32. Visseren, M. J. W., van Elsas, A., van der Voort, E. I. H., Ressing, M. E., Kast, W. M., Schrier, P. I., and Melief, C. J. M. CTL specific for the tyrosinase auto-antigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol., 154: 3991–3998, 1995.
33. Ohashi, P. S. Ignorance is bliss. Immunologist, 2: 87–92, 1994.
34. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yanelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154: 2257–2265, 1995.
35. Robbins, P. F., Elgamil, M., Kawakami, Y., and Rosenberg, S. A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54: 3124–3126, 1994.
36. Porgador, A., and Gilboa, A. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med., 182: 255–260, 1995.